Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GetRelief Rx vs Queen RX

GetRelief Rx
Graded #353

Lower grade

vs+7.399999999999999
Queen RX
Graded #192

Higher grade

The verdict

Queen RX takes it — 66.3/100 to 58.9/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +34
43
77
Dose & formulationGetRelief Rx +21
78
57
Clinical oversightGetRelief Rx +1
70
69
Labs & monitoringQueen RX +1
52
53
FulfillmentQueen RX +17
58
75
Contract termsQueen RX +14
47
61
GetRelief Rx · left barQueen RX · right bar

The numbers

MetricGetRelief RxQueen RX
WeighScore58.9/10066.3/100
GradeCC
Scorecard rank#353#192
Semaglutide$269/mo (9 mg dose, compounded oral)$100/mo (quarterly plan, compounded)
Tirzepatide$179/mo (16 mg dose, compounded oral)Not disclosed
CoverageCoverage not published45 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
GetRelief Rx

Graded #353 · C

Strengths

  • Compounded semaglutide and tirzepatide priced publicly — no login required to see costs
  • BBB accredited with an A rating (March 2026)
  • Free online assessment with no upfront consultation fee

Where it loses points

  • Sublingual drops only — no injectable; this delivery method wasn't studied in the STEP/SURMOUNT trials
  • Still sells compounded tirzepatide after the FDA ended compounding enforcement discretion in 2025
  • No LegitScript, PCAB, or NABP pharmacy certifications found
  • Prescriber credentials listed only as 'licensed clinicians' with no detail on degree type
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard